A new modelin disease-focusedphilanthropy.

Uniting philanthropy, science, and mission-aligned capital to accelerate new therapies in immunology and autoimmune disease.

LoginConnect (opens in new tab)

Supporting the cross-disease science, translational infrastructure, convening, and patient-centered initiatives no single organization can pursue alone.